Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | Phoenix PharamLabs – a privately held, pre-clinical stage drug development company headquartered in |
Description | PPL-138 Search for: HOME TECHNOLOGY I.P. STRATEGY NEWS & EVENTS TEAM CONTACT HOME PPLadmin 2023-03-13T21:54:06+00:00 Providing a pathway to potent pain therapy wi |
Keywords | N/A |
WebSite | phoenixpharmalabs.com |
Host IP | 198.71.233.187 |
Location | United States |
Site | Rank |
US$2,189,953
Last updated: 2023-05-04 00:38:11
phoenixpharmalabs.com has Semrush global rank of 4,833,120. phoenixpharmalabs.com has an estimated worth of US$ 2,189,953, based on its estimated Ads revenue. phoenixpharmalabs.com receives approximately 252,687 unique visitors each day. Its web server is located in United States, with IP address 198.71.233.187. According to SiteAdvisor, phoenixpharmalabs.com is safe to visit. |
Purchase/Sale Value | US$2,189,953 |
Daily Ads Revenue | US$2,022 |
Monthly Ads Revenue | US$60,645 |
Yearly Ads Revenue | US$727,739 |
Daily Unique Visitors | 16,846 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
phoenixpharmalabs.com. | A | 599 | IP: 198.71.233.187 |
phoenixpharmalabs.com. | NS | 3600 | NS Record: ns46.domaincontrol.com. |
phoenixpharmalabs.com. | NS | 3600 | NS Record: ns45.domaincontrol.com. |
phoenixpharmalabs.com. | MX | 3600 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.com. |
phoenixpharmalabs.com. | MX | 3600 | MX Record: 10 ALT3.ASPMX.L.GOOGLE.com. |
phoenixpharmalabs.com. | MX | 3600 | MX Record: 10 ALT4.ASPMX.L.GOOGLE.com. |
phoenixpharmalabs.com. | MX | 3600 | MX Record: 1 ASPMX.L.GOOGLE.com. |
phoenixpharmalabs.com. | MX | 3600 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.com. |
Search for: HOME TECHNOLOGY I.P. STRATEGY NEWS & EVENTS TEAM CONTACT HOME PPLadmin 2023-03-13T21:54:06+00:00 Providing a pathway to potent pain therapy without the risk of addiction and serious side effects. Phoenix is a pre-clinical pharmaceutical company driven by a mission to bring potent, safe pain therapies to market without risk of abuse and addiction. PPL-138 Our lead candidate for acute & chronic pain : PPL- 138 , represents a novel new class of analgesics with robust preclinical validation of potent pain relief (100X potency of morphine), low risk of abuse/addiction, and no respiratory depression. PPL-103 Our second drug candidate PPL-103 , offers promising potential for the treatment of addiction , as well for pain . It has also demonstrated low risk of abuse/addiction and reduced opioid side effects. Phase I We are advancing PPL-138 into Phase I human clinical trials by year end 2023. Funding More than $23 M has been raised to date from grants from the U.S. Army and |
HTTP/1.1 200 OK Accept-Ranges: bytes Age: 52098 Content-Length: 88281 Content-Type: text/html; charset=UTF-8 Date: Mon, 25 Oct 2021 13:47:55 GMT Vary: Accept-Encoding, User-Agent X-Backend: local X-Cache: cached X-Cache-Hit: HIT X-Cacheable: YES:Forced X-Content-Type-Options: nosniff X-Xss-Protection: 1; mode=block |
Domain Name: PHOENIXPHARMALABS.COM Registry Domain ID: 130781594_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2017-06-14T13:22:04Z Creation Date: 2004-09-23T20:09:27Z Registry Expiry Date: 2022-06-13T11:59:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS45.DOMAINCONTROL.COM Name Server: NS46.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T05:17:46Z <<< |